Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Onyx Scientific appoints European Business Development representative.Due to continued growth of the company’s services to Pharmaceutical and biotech companies Onyx Scientific has appointed Dr Enrico Grassi to cover mainland Europe.
By: Dr Tony Flinn “These are important biotech areas for Onyx Scientific’s services and a local contact as experienced as Enrico will undoubtedly enhance our capabilities in these areas” commented Denise Bowser, Commercial Director at Onyx Scientific. Enrico has over 24 years experience in drug discovery services and a PhD in Pharmacology/ “In the current Pharma and Biotech environment, Companies are looking more and more for reliable partners for Chemical Research and Development. I'm very pleased to collaborate with Onyx Scientific, a Company that, for many years, have been proving the capability to foresee Market trends and fully respond to the growing and changing demands from many Pharma and Biotech customers in the world.” commented Dr Grassi. Onyx Scientific Limited is a chemistry Outsourcing specialist that supplies a diverse array of chemistry research and development services to the pharmaceutical and related industries. Onyx Scientific provides contract research, custom synthesis, small-scale cGMP manufacturing, polymorphism, salt selection and other services plus novel fine chemicals based on proprietary technology. Further information on the appointment or about Onyx Scientific Ltd. can be obtained by contacting Dr. Tony Flinn: Telephone 0044 (0) 191 516 6 516 Fax 0044 (0) 191 516 6 526 Mobile Telephone: 07712 760231 Onyx Scientific Silverbriar Sunderland Enterprise Park East Sunderland Tyne and Wear SR5 2TQ, UK. e-mail: tonyflinn@onyx- # # # Onyx Scientific Limited supplies a range of chemistry R&D services to the pharmaceutical industry including contract research, custom synthesis, small-scale cGMP manufacturing, polymorphism, salt selection and other services End
Account Email Address Disclaimer Report Abuse
|
|